Regulus Therapeutics Inc. ( RGLS) - Stock Earnings
Stock symbol RGLS is outdated, potentially delisted? Maybe it is available on other exchange?
RGLS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -7.1 million USD | — USD |
| 2023Q2 | -7.0 million USD | — USD |
| 2023Q3 | -7.8 million USD | — USD |
RGLS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -27.8 million USD | 10022 USD |
| 2022 | -28.3 million USD | 0 USD |
| 2023 | -28.8 million USD | — USD |
RGLS
Price: $8.16
52 week price:
Earnings Per Share: -0.68 USD
P/E Ratio: -12
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 68300
Ebitda: -14.7 millionMarket Capitalization: 565.0 million